LenioBio raised €12M in a Series A round in Mar 2022. The company is based in Dusseldorf, Germany. Investors in the round: Bridford Group. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
